I2S S.A [ALI2S] vs Lucibel S.A [ALUCI] Detailed Stock Comparison
I2S S.A
Euronext
Loading...
Lucibel S.A
Euronext
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: I2S S.A wins in 11 metrics, Lucibel S.A wins in 4 metrics, with 0 ties. I2S S.A appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | I2S S.A | Lucibel S.A | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 10.79 | -0.67 | Lucibel S.A |
| Price-to-Book Ratio | 1.00 | N/A | N/A |
| Debt-to-Equity Ratio | 0.00 | -3.09 | Lucibel S.A |
| PEG Ratio | N/A | 0.53 | N/A |
| EV/EBITDA | 6.20 | -1.75 | Lucibel S.A |
| Profit Margin (TTM) | 0.62% | -49.76% | I2S S.A |
| Operating Margin (TTM) | 15.33% | -72.31% | I2S S.A |
| EBITDA Margin (TTM) | 15.33% | N/A | N/A |
| Return on Equity | 0.97% | -6,708.51% | I2S S.A |
| Return on Assets (TTM) | 0.58% | -23.96% | I2S S.A |
| Free Cash Flow (TTM) | $1.09M | $-1.49M | I2S S.A |
| Dividend Yield | 3.60% | N/A | N/A |
| 1-Year Return | 0.00% | -60.87% | I2S S.A |
| Price-to-Sales Ratio (TTM) | 0.66 | 0.50 | Lucibel S.A |
| Enterprise Value | $10.23M | $4.80M | I2S S.A |
| EV/Revenue Ratio | 0.56 | 0.76 | I2S S.A |
| Revenue per Share (TTM) | $11 | $0 | I2S S.A |
| Earnings per Share (Diluted) | $0.63 | $-0.14 | I2S S.A |
| Beta (Stock Volatility) | -0.03 | 0.69 | I2S S.A |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
I2S S.A vs Lucibel S.A Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| I2S S.A | 2.82% | 7.35% | 8.15% | 4.29% | -2.01% | -14.12% |
| Lucibel S.A | -2.53% | 0.00% | 12.50% | 12.50% | -43.75% | -18.18% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| I2S S.A | 0.00% | 28.07% | 84.34% | 317.14% | 188.54% | 188.54% |
| Lucibel S.A | -60.87% | -91.00% | -90.82% | -97.57% | -99.18% | -99.18% |
Performance & Financial Health Analysis: I2S S.A vs Lucibel S.A
| Metric | ALI2S | ALUCI |
|---|---|---|
| Market Information | ||
| Market Cap | €12.10M | €3.17M |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 57 | 20,637 |
| 90 Day Avg. Volume | 36 | 61,221 |
| Last Close | €7.30 | €0.09 |
| 52 Week Range | €6.65 - €9.15 | €0.07 - €0.24 |
| % from 52W High | -20.22% | -61.66% |
| All-Time High | €9.15 (Oct 28, 2024) | €12.89 (Jul 14, 2014) |
| % from All-Time High | -20.22% | -99.30% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.06% | -0.21% |
| Quarterly Earnings Growth | -0.23% | N/A |
| Financial Health | ||
| Profit Margin (TTM) | 0.01% | -0.50% |
| Operating Margin (TTM) | 0.15% | -0.72% |
| Return on Equity (TTM) | 0.01% | -67.09% |
| Debt to Equity (MRQ) | 0.00 | -3.09 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | €6.77 | €-0.03 |
| Cash per Share (MRQ) | N/A | €0.03 |
| Operating Cash Flow (TTM) | €756,516 | €-991,000 |
| Levered Free Cash Flow (TTM) | €114,163 | €45,750 |
| Dividends | ||
| Last 12-Month Dividend Yield | 3.60% | N/A |
| Last 12-Month Dividend | €0.25 | N/A |
Valuation & Enterprise Metrics Analysis: I2S S.A vs Lucibel S.A
| Metric | ALI2S | ALUCI |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 10.79 | -0.67 |
| Forward P/E | N/A | 0.53 |
| PEG Ratio | N/A | 0.53 |
| Price to Sales (TTM) | 0.66 | 0.50 |
| Price to Book (MRQ) | 1.00 | N/A |
| Market Capitalization | ||
| Market Capitalization | €12.10M | €3.17M |
| Enterprise Value | €10.23M | €4.80M |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.56 | 0.76 |
| Enterprise to EBITDA | 6.20 | -1.75 |
| Risk & Other Metrics | ||
| Beta | -0.03 | 0.69 |
| Book Value per Share (MRQ) | €6.77 | €-0.03 |
Financial Statements Comparison: I2S S.A vs Lucibel S.A
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | ALI2S | ALUCI |
|---|---|---|
| Revenue/Sales | N/A | N/A |
| Cost of Goods Sold | N/A | N/A |
| Gross Profit | N/A | N/A |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | N/A | N/A |
| EBITDA | N/A | N/A |
| Pre-Tax Income | N/A | N/A |
| Income Tax | N/A | N/A |
| Net Income (Profit) | N/A | N/A |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | ALI2S | ALUCI |
|---|---|---|
| Cash & Equivalents | €2.23M | €614,000 |
| Total Current Assets | €12.96M | €4.80M |
| Total Current Liabilities | €4.47M | €4.85M |
| Long-Term Debt | €4.42M | €3.18M |
| Total Shareholders Equity | €11.79M | €-1.03M |
| Retained Earnings | €886,737 | €-3.90M |
| Property, Plant & Equipment | €622,852 | €614,000 |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | ALI2S | ALUCI |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | ALI2S | ALUCI |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 57 | 20,637 |
| Average Daily Volume (90 Day) | 36 | 61,221 |
| Shares Outstanding | 1.66M | 25.17M |
| Float Shares | N/A | 23.90M |
| % Held by Insiders | 0.00% | 0.04% |
| % Held by Institutions | 0.02% | 0.00% |
Dividend Analysis & Yield Comparison: I2S S.A vs Lucibel S.A
| Metric | ALI2S | ALUCI |
|---|---|---|
| Last 12-Month Dividend | €0.25 | N/A |
| Last 12-Month Dividend Yield | 3.60% | N/A |
| 3-Year Avg Annual Dividend | €0.22 | N/A |
| 3-Year Avg Dividend Yield | 2.03% | N/A |
| 3-Year Total Dividends | €0.67 | N/A |
| Ex-Dividend Date | May 29, 2025 | N/A |